Insecticides India share price today

Insecticides India Ltd's share price was ₹554.70 at the close on 4 November 2026. It has been falling for 14 weeks. That is 13.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹519 and ₹749, and at that close it sat 15% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Insecticides India Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 22 weeks running.

Over the last 11 years the share price moved +158% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 19 June 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: revenue fell in the June 2026 quarter and profit down on a year earlier for 4 quarters in a row.

1. Revenue fell in the June 2026 quarter

   Revenue was ₹612 crore, -11.4% on a year earlier (₹691 crore), after 5 quarters of growth.

   Why: Revenue fell because erratic monsoon and drought pockets hurt demand, and weak sentiment made the industry cautious.

   Next results: check whether Q2 revenue turns positive after the weather disruption.

   From the earnings call on 28 Sep 2026.

2. Profit down on a year earlier for 4 quarters in a row

   In the June 2026 quarter profit was ₹44 crore, -24.1% on a year earlier.

   Why: Profit fell because sales were lower while many costs stayed fixed, so the revenue drop hit earnings harder.

   Next results: check whether the full-year margin stays above last year as more sales cover fixed costs.

   From the earnings call on 28 Sep 2026.

For April to June 2026 (the quarter ended 30 June 2026), Insecticides India reported revenue of ₹612 crore, down 11.4% from ₹691 crore a year earlier, and a profit of ₹44.0 crore, down 24.1% from ₹58.0 crore.

Insecticides India results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Insecticides India's management discussed these results on a call held on 28 September 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Insecticides India closed at ₹554.70 on 4 November 2026, down 19.3% from ₹687.50 a year earlier (7 November 2025) and up 24.6% over five years. Its highest weekly close since March 2016 was ₹1,046.30 on 25 July 2025.

Insecticides India share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

562 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Insecticides India closed at ₹554.70, up 6.8% on the week and down 2.5% on the month. 28 Sep 2026: Insecticides India held its results call for April to June 2026. Management guided: Q2 expected positive on a year earlier and H2 expected to recover first-half industry losses.

Earlier

• Results for April to June 2026: Revenue down 11.4% and profit down 24.1% on a year earlier.
• 6 Feb 2026: ex-date for an interim dividend of ₹2 a share.

Insecticides India paid ₹2 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.36% at the ₹554.70 close on 4 November 2026. The last was an interim dividend of ₹2 a share, ex-date 6 February 2026.

Insecticides India dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Insecticides India Ltd paid out 4% of its profit as dividends in FY26, and it paid a dividend in 12 of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 28 September 2026, Insecticides India's management guided: Q2 expected positive on a year earlier and H2 expected to recover first-half industry losses.

“Percentage-wise, I think it should be better than last year. It may not be significantly higher, but it should not be lower than last year.”Sandeep Agarwal, CFO, on the call for April to June 2026

What management guided

• Dahej capacity expected to be fully utilized in the coming year; existing formulation capacity already full.
• Insecticide sales returns expected at approximately 50% of last year's level.
• Full-year operating margin should be better than last year, though not significantly higher.
• KAEROS turnover expected at ₹100 crore this year.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 28 September 2026.

When Insecticides India reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Q2 revenue to turn positive on a year earlier after weather disruption - check the next results packet.

Insecticides India is on one of our India lists: 52 week high & low.

Insecticides India Ltd earned ₹44.0 Cr of net profit in the Jun 2026 quarter, −24.1% on the same quarter a year earlier. Full-year FY26 profit was ₹139 Cr. Over 10 years profit has grown 13.3% a year on average. That is 7.2% of the quarter's revenue. The same quarter a year earlier earned ₹58.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹139 Cr (−2.1% on the year before).

Why profit moved: revenue changed −11.4% on a year earlier and the margin moved −1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed −20.7% and revenue +4.2%. Profit is growing slower than sales: rising costs are taking part of the growth.

Insecticides India Ltd reported ₹612 Cr of revenue in the Jun 2026 quarter, −11.4% on the same quarter a year earlier. Over 10 years it has grown 9.0% a year on average. The last full year, FY26, came in at ₹2,140 Cr. The last four reported quarters add to ₹2,061 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹2,140 Cr, +7.0% on the year before.

Recent pace: the last four quarters grew +4.2% on average, against 9.0% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +1.3%, against +1.9% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −16.7%, against +1.2% a year (rolling over).

Insecticides India Ltd's operating margin was 11.0% in the Jun 2026 quarter, 1.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 7.0% and 16.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −1.2 percentage points on the year while gross margin changed +2.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 99% of Insecticides India Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹100 Cr of operating cash against ₹139 Cr of profit. After ₹93.0 Cr of spending on assets, ₹7.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 99% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: the bigger use of cash is spending on new assets, at 2.2× depreciation over three years. The next section checks what that spending is building.

Insecticides India Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 177 days in FY26, down from 177 days in FY21. It spent ₹208 Cr on assets over the last 3 years. Customers take 83 days to pay, and stock sits for 215 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹2,140 Cr, each day of that cycle ties up about ₹5.9 Cr, so roughly ₹1,038 Cr is tied up in the business at any time.

FY26: customers took 83 days to pay and stock sat for 215 days, about 7.1 months of sales sitting as stock, for a full cycle of 177 days, shorter than FY21's 177.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 215 days. Customers pay about 83 days after that. Suppliers are paid at 121 days. Together that makes the 177-day cycle.

Spending on assets: ₹208 Cr over the last 3 years, against ₹94.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹130 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Insecticides India Ltd's P/E is 12.9×, near the low end of its own history: it has been lower only 28% of the time. Its usual P/E (the middle reading) is 15.1×, over 10 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.